KSAT 12 localized the national story involving a statement of the World Health Organization (WHO) with an interview of Dr. Thomas Patterson, Infectious Diseases, who is leading a UT Health San Antonio-University Health System study site on remdesivir, as part of the Adaptive COVID-19 Treatment Trials (ACTT) sponsored by the National Institute of Allergy and Infectious Diseases. Find his story by clicking on the link and scrolling down to the second video window
